Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT02064036 at 2026-07-30T19:34:18.792Z. Its registry update date was 2022-10-18, and PeptideScanner's reviewed identity mapping was leuprolide.↗
PeptideScanner retained ClinicalTrials.gov record NCT02064036 at 2026-07-30T19:34:18.792Z. Its registry update date was 2022-10-18, and PeptideScanner's reviewed identity mapping was leuprolide. 1
This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1
Complete submitted registry timeline
ClinicalTrials.gov lists these public versions with submitted dates from February 14, 2014 through October 16, 2022. Each entry links to the exact public source version and reports only the source-declared status, study type, dates, and changed-module labels.
Source-declared changed modules: None listed for this version
Source-declared changed modules: Arms and Interventions, IPDSharing, Sponsor/Collaborators, Study Description, Study Identification, Study Status
Source-declared changed modules: Study Identification, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Eligibility, Outcome Measures, Study Description, Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Contacts/Locations, Study Design, Study Status
ClinicalTrials.gov · Official source · Source checked August 9, 2026